Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Work Place Health Promotion: a Change Project (NCT01366950)University of Southern Denmark2011-06-01
Phenylketonuria, Oxidative Stress, and BH4 (NCT01395394)Emory University2011-06-01
Vitamin A Absorption From Cassava in Women (NCT01381276)USDA, Western Human Nutrition Research Center2011-06-01
A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model (NCT01397227)Crucell Holland BV2011-06-01
Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 Months (NCT01378988)Hospira, now a wholly owned subsidiary of Pfizer2011-06-01
Decitabine for High-Risk Sickle Cell Disease (NCT01375608)National Heart, Lung, and Blood Institute (NHLBI)2011-06-01
Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX (NCT01396707)Asan Medical Center2011-06-01
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001) (NCT01335191)Thymon, LLC2011-06-01
Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT01377298)National Taiwan University Hospital2011-06-01
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) (NCT01391338)Astellas Pharma Inc2011-06-01
Neoadjuvant Pazopanib in Renal Cell Carcinoma (NCT01361113)UNC Lineberger Comprehensive Cancer Center2011-06-01
Study of ExAblate Focused Ultrasound Ablation of Breast Cancer (NCT01620359)InSightec2011-06-01
Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis (NCT02280616)Dr. Falk Pharma GmbH2011-06-01
A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease (NCT01267994)Andrea Vambutas2011-06-01
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) (NCT01110876)M.D. Anderson Cancer Center2011-06-01
Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD) (NCT01373008)Bnai Zion Medical Center2011-06-01
Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes (NCT01338870)Pfizer2011-06-01
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery (NCT01416662)Federation Francophone de Cancerologie Digestive2011-06-01
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial (NCT01463605)Chinese Academy of Medical Sciences2011-06-01
Safety Study of Dabigatran in CADASIL (NCT01361763)S. Andrea Hospital2011-06-01
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction (NCT01360086)Federation Francophone de Cancerologie Digestive2011-06-01
Effectiveness of Telephone Intervention for Colorectal Cancer Caregivers (NCT01519895)Hospital Authority, Hong Kong2011-06-01
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia (NCT01325337)Allergan2011-06-01
PATH Partnering to Achieve Tobacco-free Health (NCT01533974)Fred Hutchinson Cancer Center2011-06-01
Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT) (NCT01290562)University Health Network, Toronto2011-06-01
ESBA105 in Patients With Severe Dry Eye (NCT01338610)Alcon Research2011-06-01
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM) (NCT01407003)Novartis Pharmaceuticals2011-06-01
Vitamin Therapy in JGH Patients (NCT01630720)Jewish General Hospital2011-06-01
Cavitation Ultrasound in Treatment of Patients With PCOS (NCT01622257)Ain Shams University2011-06-01
Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (NCT01282476)Massachusetts General Hospital2011-06-01
Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta (NCT01417091)Ultragenyx Pharmaceutical Inc2011-06-01
Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism) (NCT01452100)University Hospital, Toulouse2011-06-01
Tolvaptan for In-hospital Hyponatremia (NCT01386372)Mario Negri Institute for Pharmacological Research2011-06-01
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis (NCT01273779)Agennix2011-06-01
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery (NCT01346969)Pfizer2011-06-01
Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus (NCT01338883)Tobira Therapeutics, Inc.2011-06-01
Medtronic Reveal XT Study (NCT01526343)Washington University School of Medicine2011-06-01
Manuka Honey Irrigation After Sinus Surgery (NCT01350193)St. Paul's Hospital, Canada2011-06-01
The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer (NCT01331525)University Hospital Southampton NHS Foundation Trust2011-06-01
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer (NCT01367002)Yale University2011-06-01
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa (NCT01560715)University of Sao Paulo2011-06-01
ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) (NCT04154852)University of Leeds2011-06-01
Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures (NCT01370564)Medtronic Cardiac Rhythm and Heart Failure2011-06-01
A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women (NCT01384188)Ono Pharmaceutical Co., Ltd.2011-06-01
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care (NCT01359644)Bristol-Myers Squibb2011-06-01
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer (NCT01478308)New Mexico Cancer Research Alliance2011-06-01
A Phase IIa Study of NT-KO-003 for Multiple Sclerosis (NCT01428726)Neurotec Pharma2011-06-01
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C (NCT01312454)Alcon Research2011-06-01
Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer (NCT01326481)Tracon Pharmaceuticals Inc.2011-06-01
A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer (NCT01380769)NewLink Genetics Corporation2011-06-01
Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01312818)Masonic Cancer Center, University of Minnesota2011-06-01
Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer (NCT01772979)Catholic University of the Sacred Heart2011-06-01
Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients (NCT01384422)Lakefront Biotherapeutics NV2011-06-01
Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure. (NCT01971034)Instituto do Cancer do Estado de São Paulo2011-06-01
A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations (NCT01153984)Hoffmann-La Roche2011-06-01
PT003 MDI Dose Confirmation Study (NCT01349816)Pearl Therapeutics, Inc.2011-06-01
A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer (NCT01685190)Institute of Cancer Research, United Kingdom2011-06-01
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility (NCT01379183)Mayo Clinic2011-06-01
Phase 2 Chronic Low Back Pain Study (NCT01364922)AbbVie (prior sponsor, Abbott)2011-06-01
A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma (NCT01377025)Prof. Dr. med. Max. E. Scheulen2011-06-01
Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease (NCT01605513)The First Hospital of Jilin University2011-06-01
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen (NCT01365130)howard safran2011-06-01
Cognitive Remediation for Cocaine Dependence (NCT01393457)The University of Texas Health Science Center, Houston2011-06-01
The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer (NCT01193530)M.D. Anderson Cancer Center2011-06-01
Bioavailability of Amoxicillin Dissolved in Human Milk (NCT01435824)The Hospital for Sick Children2011-06-01
Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery (NCT01220739)University of California, San Diego2011-06-01
Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy (NCT01838538)Chinese PLA General Hospital2011-06-01
Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma (NCT01319422)Yale University2011-06-01
Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis (NCT01330628)Spectranetics Corporation2011-06-01
The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions (NCT02166554)BioRegen Biomedical (Changzhou) Co., Ltd2011-06-01
Outcome and Treatment of Complex Sleep Apnea (NCT01137214)University of Manitoba2011-06-01
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) (NCT01352520)M.D. Anderson Cancer Center2011-06-01
Flavanols and Skin Photo Protection: a Clinical Trial (NCT01444625)Laval University2011-06-01
AL-54478 Proof of Concept Study (NCT01318252)Alcon Research2011-06-01
Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate (NCT01373151)CSL Behring2011-06-01
Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age (NCT01127204)ANRS, Emerging Infectious Diseases2011-06-01
Trial of Endostar Combined With CHOPT for T Cell Lymphoma (NCT01430013)Tianjin Medical University Cancer Institute and Hospital2011-06-01
The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium (NCT01801137)Hopital Foch2011-06-01
Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease (NCT01394926)GE Healthcare2011-06-01
Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis (NCT01320553)Sun Pharma Advanced Research Company Limited2011-06-01
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer (NCT01358071)AGC Biologics S.p.A.2011-06-01
The Effects of a Stainless Steel Suture MGH Flexor Tendon Repair Coupled With Early Aggressive Range of Motion Rehabilitation: a Randomized Controlled Trial (NCT01344980)University of Manitoba2011-06-01
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance (NCT01373242)University of North Carolina, Chapel Hill2011-06-01
Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex in Alcoholism (NCT01330394)Federal University of Espirito Santo2011-06-01
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (NCT01361334)University Hospital Muenster2011-06-01
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss (NCT01325350)Allergan2011-06-01
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer (NCT01373164)Eli Lilly and Company2011-06-01
An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors (NCT01397929)Basilea Pharmaceutica2011-06-01
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease (NCT01569516)Changchun Huayang High-tech Co., Ltd2011-06-01
Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population (NCT01411202)Ottawa Hospital Research Institute2011-06-01
A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients (NCT01300858)EGEN, Inc.2011-06-01
TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC) (NCT01362361)Martin-Luther-Universität Halle-Wittenberg2011-06-01
Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma (NCT01377220)Commissariat A L'energie Atomique2011-06-01
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer (NCT01335204)Medical University of South Carolina2011-06-01
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients (NCT01368107)Centre Leon Berard2011-06-01
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies (NCT01364727)Heather Wakelee2011-06-01
Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants (NCT01421121)Sinovac Biotech Co., Ltd2011-06-01
H5N1 Vaccine Study in Japanese Adults (NCT01382329)Alachua Government Services, Inc.2011-06-01
YF476 and Type I Gastric Carcinoids (Norway) (NCT01444014)Trio Medicines Ltd.2011-06-01
Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer (NCT02188615)Chengchu Zhu2011-06-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.